同益股份(300538) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 reached ¥724,455,361.75, representing a 30.18% increase compared to ¥556,502,646.85 in the same period last year[3] - Net profit attributable to shareholders decreased by 6.29% to ¥3,230,388.67 from ¥3,447,354.32 year-on-year[3] - Total operating revenue for the current period reached ¥724,455,361.75, a significant increase of 30.1% compared to ¥556,502,646.85 in the previous period[21] - Net profit for the current period was ¥3,618,182.85, a decrease of 7.9% from ¥3,929,964.66 in the previous period[21] - The company reported a total comprehensive income of ¥3,376,323.41, down from ¥4,211,110.40, reflecting a decline of 19.8%[23] - The basic earnings per share for the current period was ¥0.0179, down from ¥0.0189 in the previous period[23] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly, with a net outflow of ¥10,043,614.19, an 86.08% increase compared to a net outflow of ¥72,128,538.20 in the previous year[11] - Cash and cash equivalents at the end of the period totaled $209,530,171.27, down from $390,812,249.15 in the previous period[26] - Cash outflow for investing activities was $67,820,288.31, compared to $37,729,410.43 in the previous period, indicating increased investment[26] - Net cash flow from financing activities was -$356,224.03, a decrease from $2,073,593.49 in the previous period, reflecting reduced financing activities[26] - Cash paid for taxes was $6,448,655.15, down from $15,872,018.96 in the previous period, indicating improved tax management[25] Assets and Liabilities - The company's total assets increased by 0.59% to ¥2,196,463,132.82 from ¥2,183,671,118.39 at the end of the previous year[3] - The company's total liabilities increased to ¥1,221,616,092.06 from ¥1,212,206,517.62, marking a growth of 0.9%[20] - Total equity rose to ¥974,847,040.76, compared to ¥971,464,600.77, indicating a slight increase of 0.4%[20] - The company's inventory increased by 58.87% to ¥347,288,365.41 from ¥218,596,507.41 at the beginning of the year[6] - Accounts receivable increased to CNY 502,312,158.04 from CNY 488,847,887.16, showing a growth of about 2.9%[19] Research and Development - Research and development expenses decreased by 33.62% to ¥2,630,489.11 from ¥3,962,609.40 year-on-year[9] - Research and development expenses decreased to ¥2,630,489.11 from ¥3,962,609.40, a reduction of 33.6%[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 18,640[12] - The top ten unrestricted shareholders hold a total of 28,000,000 shares, with the largest shareholder owning 9,741,690 shares[14] - The company has a total of 68,777,092 restricted shares, with 1,938,398 shares released during the current period[16] - The company has not reported any changes in the participation of major shareholders in margin trading activities[14] Future Plans - The company plans to use CNY 1.8 billion of idle raised funds temporarily to supplement working capital, with a repayment period of 12 months[17] - The company plans to focus on market expansion and new product development as part of its future strategy[22]